In a new study, researchers at Uppsala University have been able to show differences in how rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic ...
Dec 11, 2020
0
3
Despite the success of immunotherapy in the treatment of cancers such as lung or melanoma, it is still not effective in breast cancers for being 'cold', with low infiltration of immune cells. Tumors use strategies to evade ...
Dec 10, 2020
0
8
For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to help people with metastatic bowel cancer.
Nov 26, 2020
0
59
Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available 10 years ago. However, there are certain types of cancer that do not respond to existing immunotherapy. ...
Nov 23, 2020
0
87
A preclinical study conducted at the Institute of Oncology Research (IOR, affiliated to USI Università dellaSvizzera italiana) reveals the role of aging cells in the formation of metastases and identifies a drug capable ...
Nov 13, 2020
0
122
The latest animation technology has revealed the molecular detail of how our bodies are protected from cancer by a key 'tumour suppressor' protein called p53.
Nov 11, 2020
0
15
Before an effective treatment can be devised, researchers have to understand the specific effect of an anti-cancer substance on the cell type, or even the cell, that produces metastases in the enormous cellular heterogeneity ...
Nov 10, 2020
0
38
University of Calgary scientists and members of the Clark H. Smith Brain Tumor Centre at the Arnie Charbonneau Cancer Institute at the Cumming School of Medicine (CSM) have discovered a way to stop the growth of glioblastoma, ...
Oct 27, 2020
0
4
When immune system T cells find and recognize a target, they release chemicals to attract more T cells which then swarm to help subdue the threat, shows a new study published today in eLife.
Oct 13, 2020
0
8
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) reports that exosomes derived from Vδ2-T cells (Vδ2-T-Exos) can effectively control Epstein-Barr-virus-associated tumors and induce T-cell ...
Oct 12, 2020
0
57
